Table 2.
Cytotoxicity of compounds 2–5 against human breast and cervical cancer cell lines.
Compound | IC50 (μM) | |
---|---|---|
MCF-7 | CaSki | |
2 | − a | 22.81 ± 1.33 |
3 | 17.30 ± 2.11 | 24.44 ± 0.22 |
4 | 20.10 ± 1.52 | 25.59 ± 1.70 |
5 | 14.47 ± 0.51 | 21.95 ± 2.56 |
Doxorubicin | 0.06 ± 0.01 | 0.20 ± 0.02 |
a IC50 > 10 μg/mL.